Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
12/2010
12/29/2010WO2010148631A1 Dihydropyrimidine compounds and preparation methods, pharmaceutical compositions and uses thereof
12/29/2010WO2010129848A3 2,6-dioxo-1,2,3,6-tetrahydropyrimidine-4-carboxamides
12/29/2010WO2010113183A3 Process for the preparation of 1-[[[3-[2-(dimethylamino)ethyl]-1h-indol-5-yl]methyl]sulfonyl] pyrrolidine and its pharmaceutically acceptable salts
12/29/2010WO2010029457A3 An improved process for preparing losartan potassium
12/29/2010EP2266977A1 2,4-di[(hetero)arylamino]-pyrimidine derivatives as zap-70 and/or syk inhibitors
12/29/2010EP2266973A1 Pyrazinylpyrazole
12/29/2010EP2266970A1 Substituted aromatic heterocyclic compounds as fungicides
12/29/2010EP2266964A1 Acid-labile trigger units
12/29/2010EP2266960A2 Aryl-substituted pyrazoles, imidazoles, oxazoles, thiazoles and pyrroles as anticonvulsants
12/29/2010EP2266958A1 Antiviral agent
12/29/2010EP2266583A1 Gene expression inhibitor selective for matrix metalloproteinase-9 gene
12/29/2010EP2266569A2 Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors
12/29/2010EP2265606A1 Hepatitis c virus inhibitors
12/29/2010EP2265604A2 Heteroaryl-substituted bicyclic smac mimetics and the uses thereof
12/29/2010EP2265603A1 Inhibitors of the bmp signaling pathway
12/29/2010EP2265602A1 Substituted dihydropyrazolones as inhibitors of hif-prolyl-4-hydroxylases
12/29/2010EP2265601A1 Pyridazine derivatives as factor xia inhibitors
12/29/2010EP2265598A2 Novel hsp90 inhibitory carbazole derivatives, compositions containing same, and use thereof
12/29/2010EP2265592A1 Substituted pyraz inylmethyl sulfonamides for use as. fungicides
12/29/2010EP2265589A1 Arylsulfonyl pyrazoline carboxamidine derivatives as 5-ht6 antagonists
12/29/2010EP2265587A1 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto
12/29/2010EP2265582A1 Novel 3-aminoalkyl-1,3-dihydro-2h-indol-2-one derivatives, preparation thereof and therapeutic use thereof.
12/29/2010EP2265580A1 Novel method for the production of sulphonylpyrroles as hdac inhibitors
12/29/2010EP2265335A1 Indazole derivatives
12/29/2010EP2265273A1 Hexahydrocyclopentyl[f] indazole sulfonamides and derivatives thereof as selective glucocorticoid receptor modulators
12/29/2010EP2049519B9 Cyclic derivatives as modulators of chemokine receptor activity
12/29/2010EP1871768B1 Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine d3 receptors
12/29/2010EP1861377B1 Benzimidazolone derivatives as cb2 receptor ligands
12/29/2010EP1791830B1 Diaminotriazole compounds useful as protein kinase inhibitors
12/29/2010EP1530568B1 INDOLE OR BENZIMIDAZOLE DERIVATIVES FOR MODULATING I&kB KINASE
12/29/2010EP1438052B1 Quinazolin-4-ones as inhibitors of human phosphatidylinositol 3-kinase delta
12/29/2010EP1001946B1 QUINOXALINE COMPOUNDS WHICH INHIBIT PLATELET-DERIVED GROWTH FACTOR AND/OR p56lck TYROSINE KINASES
12/29/2010CN1926132B Pyrazole compounds useful as protein kinase inhibitors
12/29/2010CN1922139B Bicyclic amide derivatives
12/29/2010CN101932574A 1,2,4,-triazin-3,5-dione compounds for treating disorders that respond to modulation of the dopamine d3 receptor
12/29/2010CN101932562A Carbamoyl compounds as dgat1 inhibitors 190
12/29/2010CN101928284A Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
12/29/2010CN101142193B Propane-1,3-dion derivative or salt thereof
12/29/2010CA2766550A1 Benzamide derivatives
12/29/2010CA2766320A1 Acid-labile trigger units
12/29/2010CA2765983A1 1, 3-disubstituted imidazolidin-2-one derivatives as inhibitors of cyp 17
12/29/2010CA2764422A1 Insecticidal compounds
12/28/2010US7858808 synthesis of new class of nonsteroidal antiinflammatory and antibacterial agent for use treating septic shock, asthma, arthritis, cancer; e.g. 1-Benzyl-2,4,5-triphenyl-4,5-dihydro-1H-imidazole-4-carboxylic acid
12/28/2010US7858804 Process for making cytokine inhibiting compounds containing 4- and 5-imidazolyl rings and the intermediates thereof
12/28/2010US7858786 Pyrimidines and pyrazines useful as modulators of ion channels
12/28/2010US7858782 e.g. N-(2-chloro-6-methylphenyl)-3-ethoxyacrylamide; protein (tyrosine and serine/threonine) kinase inhibitor; variety of conditions and diseases; antiproliferative, anticarcinogenic, antiinflammatory, antiallergenic agent; autoimmune and neurodegenerative disorders
12/28/2010US7858781 inflammatory conditions, allergies, autoimmune diseases, chronic pain, graft rejection, cancers which involve leukocyte filtration, stenosis or restenosis, atherosclerosis, rheumatoid arthritis, osteoarthritis; e.g. 4-Isobutoxy-1H-indole-2-carboxylic acid [4-(2-azepan-1-yl-ethyl)-phenyl]-amide
12/28/2010US7858652 e.g.1-(1H-imidazol-4-ylmethyl)-2-methyl-2,3-dihydro-1H-indole; trace amine associated receptors (g-protein coupled receptor), especially TAAR1; antidepressant, anxiolytic agent; psychosis, Parkinson's disease; reductively amination and coupling of indole and 5-methylketone-imidazol
12/28/2010US7858645 Indazole derivatives
12/28/2010US7858642 Substituted hydroxyethylamine aspartyl protease inhibitors
12/28/2010US7858641 melanocortin-4 receptor (MC4-R) agonists such as (3R,5S)-N-(2-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-1-oxo-1,2-dihydroisoquinolin-6-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used for the treatment of obesity or diabetes
12/28/2010US7858633 Cycloalkyl substituted pyrimidinediamine compounds and their uses
12/28/2010US7858632 Purinergic receptor antagonists; genitourinary and pain-related diseases; for example, 5-(2-isopropyl-4,5-dimethoxybenzyl)-pyrimidine-2,4-diamine
12/28/2010US7858631 such as (3R,5S)-N-(3-{2-[2-fluoro-4-(methyloxy)phenyl]ethyl}-4-oxo-3,4-dihydropyrido[2,3-d]pyrimidin-7-yl)-3,5-dimethyl-N'-[(1S,2S,3S,5R)-2,6,6-trimethylbicyclo[3.1.1]hept-3-yl]piperazine-1-carboximidamide, used as melanocortin-4 receptor (MC4-R) agonists, for the treatment of obesity or diabetes
12/28/2010US7858626 Pyrimidineamines as angiogenesis modulators
12/28/2010US7858624 such as methyl 2-((R)-((R)-1-((2S,3S)-5-(butylamino)-1-cyclohexyl-3-hydroxy-5-oxopentan-2-ylcarbamoyl)piperidin-3-yl)(3-chlorophenyl)methoxy)ethylcarbamate, used as hypotensive agents or for the treatment of cardiovascular disorders, vision defects, aldosteronism and obesity
12/28/2010US7858211 Organic electroluminescent device
12/23/2010WO2010146595A2 Novel polymorphs of flibanserin hydrochloride
12/23/2010WO2010146133A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010WO2010146132A1 Sulfonamides and sulfamides as zap-70 inhibitors
12/23/2010WO2010145991A1 Phenanthroazole compounds as hole transporting materials for electro luminescent devices
12/23/2010WO2010145883A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/23/2010WO2010145668A1 Novel phenylimidazole derivative as pde10a enzyme inhibitor
12/23/2010WO2010145186A1 Peptide deformylase inhibitor containing 2,5-dihydropyrrole and synthesis method thereof
12/23/2010US20100324273 Compounds, complexes and uses thereof
12/23/2010US20100324266 Photocleavable Protecting Groups
12/23/2010US20100324130 Daa peripheral benzodiazepine receptor ligand for cancer imaging and treatment
12/23/2010US20100324061 Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
12/23/2010US20100324029 Therapeutic agents
12/23/2010US20100324020 Bicyclic [3.1.0] Heteroaryl Amides As Type 1 Glycine Transport Inhibitors
12/23/2010US20100324017 Acylguanidine derivative
12/23/2010US20100324016 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324015 Heteroaromatic and aromatic piperazinyl azetidinyl amides as monoacylglycerol lipase inhibitors
12/23/2010US20100324014 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324013 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324012 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324011 Azetidinyl diamides as monoacylglycerol lipase inhibitors
12/23/2010US20100324009 Substituted Sulfonamide Compounds
12/23/2010US20100323999 Therapeutic Molecules and Methods-1
12/23/2010US20100323389 Fluorescent imaging with substituted cyanine dyes
12/23/2010US20100322980 Pyrimidine derivatives useful for the treatment of diseases mediated by crth2
12/23/2010CA2765750A1 Novel phenylimidazole derivative as pde10a enzyme inhibitor
12/23/2010CA2763730A1 Heterocyclylaminopyrimidines as kinase inhibitors
12/23/2010CA2763720A1 Sulfonamides and sulfamides as zap-70 inhibitors
12/23/2010CA2755467A1 Novel substituted indazole and aza-indazole derivatives as gamma secretase modulators
12/22/2010EP2265092A1 Electroluminescent device
12/22/2010EP2264106A1 Azo pigment composition, process for production of the composition, dispersions containing the composition, colored compositions and jet printing ink
12/22/2010EP2264032A2 Hiv protease inhibiting sulfonamides
12/22/2010EP2264030A1 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
12/22/2010EP2264028A1 Pyrazole compounds useful as protein kinase inhibitors
12/22/2010EP2264027A1 Process for the preparation of N-[2-(Diethylamino)ethyl]-5-[(5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene) methyl]-2,4-dimethyl-1H-pyrrole-3-carboxamide
12/22/2010EP2264014A1 Substituted pyridazines as anti-inflammatory agents and protein kinase inhibitors
12/22/2010EP2263669A1 Pharmaceutically active isoindoline derivatives
12/22/2010EP2262808A2 Chemokine receptor modulators
12/22/2010EP2262796A1 Aurora kinase inhibitors
12/22/2010EP2262783A2 Covalently binding imaging probes
12/22/2010EP2262767A1 Novel triaryl derivatives useful as modulators of nicotinic acetylcholine receptors
12/22/2010EP2262496A1 Compounds and compositions as modulators of gpr119 activity
12/22/2010EP2061774B1 Arylpiperazine derivatives and uses thereof
12/22/2010EP1915345B1 Fluoro substituted 2-oxo azepan derivatives
1 ... 127 128 129 130 131 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 ... 626